Galectin-8 in IgA Nephritis: Decreased binding of IgA by galectin-8 affinity chromatography and associated increased binding in Non-IgA serum glycoproteins

Journal of Clinical Immunology

Volumn 32, Issue 2, 2012, Pages 246-255

  Carlsson, Michael C ^a   Bakoush, Omran ^b   Tengroth, Lotta ^a   Kilsgård, Ola ^a   Malmström, Johan ^a   Hellmark, Thomas ^b   Segelmark, Mårten ^b,c   Leffler, Hakon ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Affinity chromatography; Galectin 8; IgA nephropathy; NeuAc 2 3Gal

Indexed keywords

GALECTIN 8; GLYCOPROTEIN; IMMUNOGLOBULIN A; GALECTIN; LGALS8 PROTEIN, HUMAN;

ADULT; AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; AGED; BLOOD; DISEASE COURSE; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; GALECTINS; GLOMERULONEPHRITIS, IGA; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; PROTEIN BINDING; YOUNG ADULT;

EID: 84863560786     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9618-3     Document Type: Article

References (48)

1. Berger J, Hinglais N. Intercapillary deposits of IgA-IgG. J Urol Nephrol (Paris). 1968;74(9):694-5.
2. Gharavi AG, Yan Y, Scolari F, Schena FP, Frasca GM, Ghiggeri GM, et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet. 2000;26(3):354-7.
3. Novak J, Julian BA, Tomana M, Mesteck J. Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol. 2001;21 (5):310-27. (Pubitemid 33015802)
4. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol. 2008;19(5):1008-14.
5. Izzi C, Sanna-Cherchi S, Prati E, Belleri R, Remedio A, Tardanico R, et al. Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. Kidney Int. 2006;69 (6):1033-40. (Pubitemid 43372178)
6. Segelmark M, Hellmark T. Autoimmune kidney diseases. Autoimmun Rev. 2010;9(5):A366-71. doi:10.1016/j.autrev.2009.11.007.
7. Bisceglia L, Cerullo G, Forabosco P, Torres DD, Scolari F, Di Perna M, et al. Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am J Hum Genet. 2006;79(6):1130-4. (Pubitemid 44853485)
8. Paterson AD, Liu XQ, Wang K, Magistroni R, Song X, Kappel J, et al. Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. J Am Soc Nephrol. 2007;18(8):2408-15. (Pubitemid 47203857)
9. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barratt J, Feehally J. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int. 2001;60(3):969-73. (Pubitemid 34205796)
10. Barratt J, Smith AC, Feehally J. The pathogenic role of IgA1 Olinked glycosylation in the pathogenesis of IgA nephropathy. Nephrology (Carlton). 2007;12(3):275-84. (Pubitemid 46718210)
11. Coppo R, Amore A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int. 2004;65(5):1544-7. (Pubitemid 38590997)
12. Czerkinsky C, Koopman WJ, Jackson S, Collins JE, Crago SS, Schrohenloher RE, et al. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Investig. 1986;77 (6):1931-8. (Pubitemid 16062650)
13. Qin W, Zhou Q, Yang LC, Li Z, Su BH, Luo H, et al. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med. 2005;258(5):467-77. (Pubitemid 41546563)
14. Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Investig. 2008;118(2):629-39. (Pubitemid 351206552)
15. Zhu L, Tang W, Li G, Lv J, Ding J, Yu L, et al. Interaction between variants of two glycosyltransferase genes in IgA nephropathy. Kidney Int. 2009;76(2):190-8.
16. Allen AC, Harper SJ, Feehally J. Galactosylation of N- and Olinked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol. 1995;100(3):470-4.
17. Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int. 2005;68(1):167-72.
18. Hiki Y. O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy. Clin Exp Nephrol. 2009;13(5):415-23.
19. Floege J. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches? Am J Kidney Dis. 2011. doi:10.1053/j.ajkd. 2011.05.033.
20. Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, et al. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study. Biochemistry. 2010;49 (27):5671-82. doi:10.1021/bi9019498.
21. Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber- Krol MC, Eijgenraam JW, et al. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. J Am Soc Nephrol. 2006;17 (12):3529-39. doi:10.1681/ASN.2006040388. (Pubitemid 44865296)
22. Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F. Introduction to galectins. Glycoconj J. 2004;19(7-9):433-40. (Pubitemid 38316516)
23. Ideo H, Matsuzaka T, Nonaka T, Seko A, Yamashita K. Galectin-8-N-domain recognition mechanism for sialylated and sulfated glycans. J Biol Chem. 2011;286(13):11346-55. doi:10.1074/jbc.M110.195925.
24. Carlsson S, Oberg CT, Carlsson MC, Sundin A, Nilsson UJ, Smith D, et al. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology. 2007;17(6):663-76. (Pubitemid 47062709)
25. Cederfur C, Salomonsson E, Nilsson J, Halim A, Oberg CT, Larson G, et al. Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins. Glycobiology. 2008;18(5):384-94. (Pubitemid 351560539)
26. Liu FT, Rabinovich GA. Galectins: regulators of acute and chronic inflammation. Ann N Y Acad Sci. 2010;1183:158-82. doi:10.1111/j.1749-6632.2009. 05131.x.
27. Rabinovich GA, Toscano MA. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol. 2009;9(5):338-52. doi:10.1038/nri2536.
28. Levy Y, Arbel-Goren R, Hadari YR, Eshhar S, Ronen D, Elhanany E, et al. Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem. 2001;276(33):31285-95. doi:10.1074/jbc.M100340200. (Pubitemid 37384999)
29. Carcamo C, Pardo E, Oyanadel C, Bravo-Zehnder M, Bull P, Caceres M, et al. Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells. Exp Cell Res. 2006;312(4):374-86. doi:10.1016/j.yexcr.2005.10.025. (Pubitemid 41805095)
30. Hadari YR, Arbel-Goren R, Levy Y, AmsterdamA, Alon R, Zakut R, et al. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci. 2000;113(Pt 13):2385-97. (Pubitemid 30599342)
31. Arbel-Goren R, Levy Y, Ronen D, Zick Y. Cyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8. J Biol Chem. 2005;280(19):19105-14. (Pubitemid 41379617)
32. Carlsson MC, Cederfur C, Schaar V, Balog CIA, Lepur A, Touret F, et al. Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients. PLoS One. 2011;6(10):e26560.
33. Eshkar Sebban L, Ronen D, Levartovsky D, Elkayam O, Caspi D, Aamar S, et al. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J Immunol. 2007;179(2):1225-35.
34. Carlsson S, Carlsson MC, Leffler H. Intracellular sorting of galectin-8 based on carbohydrate fine specificity. Glycobiology. 2007;17(9):906-12. (Pubitemid 47423880)
35. Mattu TS, Pleass RJ, Willis AC, Kilian M, Wormald MR, Lellouch AC, et al. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J Biol Chem. 1998;273 (4):2260-72. (Pubitemid 28069279)
36. Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 2007;71 (11):1148-54. doi:10.1038/sj.ki.5002185. (Pubitemid 46809135)
37. Hashim OH, Shuib AS, Chua CT. Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains. Nephron. 2001;89(4):422-5. (Pubitemid 33135822)
38. Lahm H, Andre S, Hoeflich A, Kaltner H, Siebert HC, Sordat B, et al. Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconj J. 2004;20(4):227-38. doi:10.1023/B:GLYC.0000025817.24297. 17. (Pubitemid 39090669)
39. Tsai CM, Guan CH, Hsieh HW, Hsu TL, Tu Z, Wu KJ, et al. Galectin-1 and galectin-8 have redundant roles in promoting plasma cell formation. J Immunol. 2011;187(4):1643-52. doi:10.4049/jimmunol.1100297.
40. Cueni LN, Detmar M. Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions. Exp Cell Res. 2009;315(10):1715-23. doi:10.1016/j.yexcr.2009.02.021.
41. Ostalska-Nowicka D, Zachwieja J, Nowicki M, Kaczmarek E, Siwinska A, Witt M. Immunohistochemical detection of galectin-1 in renal biopsy specimens of children and its possible role in proteinuric glomerulopathies. Histopathology. 2007;51(4):468-76. doi:10.1111/j.1365-2559.2007.02818.x. (Pubitemid 47437842)
42. Kang EH, Moon KC, Lee EY, Lee YJ, Lee EB, Ahn C, et al. Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis. Lupus. 2009;18(1):22-8. doi:10.1177/0961203308094361.
43. Yamamoto H, Nishi N, Shoji H, Itoh A, Lu L-H, Hirashima M, et al. Induction of cell adhesion by galectin-8 and its target molecules in Jurkat T-cells. J Biochem. 2008;143(3):311-24. doi:10.1093/jb/mvm223. (Pubitemid 351363944)
44. Delacour D, Koch A, Jacob R. The role of galectins in protein trafficking. Traffic. 2009;10(10):1405-13. doi:10.1111/j.1600-0854.2009.00960.x.
45. Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, Demetriou M, et al. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell. 2007;129(1):123-34. doi:10.1016/j.cell.2007.01.049. (Pubitemid 46507588)
46. Novak J, Julian BA, Tomana M, Mestecky J. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol. 2008;28(1):78-87.
47. Romaniuk MA, Tribulatti MV, Cattaneo V, Lapponi MJ, Molinas FC, Campetella O, et al. Human platelets express and are activated by galectin-8. Biochem J. 2010;432(3):535-47. doi:10.1042/BJ20100538.
48. Ono T, Liu N, Makino T, Nogaki F, Nomura K, Muso E, et al. Role of mesangial Factor Vexpression in crescent formation in rat experimental mesangioproliferative glomerulonephritis. J Pathol. 2004;204(2):229-38. doi:10.1002/path.1620. (Pubitemid 39335297)